BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Apollomics, Inc. Presents Positive Preclinical Data on APL-102, an oral Multi-Kinase Inhibitor with CSF-1R Activity

  Activity Demonstrated as a Single Agent and in Combination with an anti-PD-1 antibody

  April 1, 2019

   · 

  3 min read
• 

  Business

  NervGen Pharma Appoints Amy Franke as VP, Clinical Operations

  Vancouver, British Columbia-- - NervGen Pharma Corp., a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, announced the appointment of Amy Franke as the Company’s Vice President, Clinical Operations.

  April 1, 2019

   · 

  6 min read
• Business

  Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations

  Dr. Sarah Fakih joined MorphoSys AG as Vice President and Head of Corporate Communications and Investor Relations effective April 1, 2019.

  April 1, 2019

   · 

  4 min read
• 

  Drug Development

  Esperion Announces Publication in The Journal of the American Heart Association of Bempedoic Acid Study 3 Results

  Study 3 Demonstrated Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP in Patients Considered Statin Intolerant

  April 1, 2019

   · 

  9 min read